Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
28.15 USD | +1.59% | -7.43% | +22.76% |
Kurzporträt
Mitarbeiterzahl: 124
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Peptide-based Therapeutics
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125.73% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125.73% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01.12.08 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 18.04.22 |
Chief Tech/Sci/R&D Officer | - | 01.07.17 | |
Samuel Saks
CTO | Chief Tech/Sci/R&D Officer | 69 | 24.05.18 |
Arturo Molina
CTO | Chief Tech/Sci/R&D Officer | 65 | 07.11.22 |
Craig Ostroff
LAW | General Counsel | - | - |
Carena Spivey
HRO | Human Resources Officer | - | - |
Suneel Gupta
PRN | Corporate Officer/Principal | 66 | 17.01.19 |
Ashok Bhandari
PRN | Corporate Officer/Principal | - | 01.01.17 |
Carter J. King
PRN | Corporate Officer/Principal | 52 | 01.09.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 08.06.17 |
Harold Selick
CHM | Chairman | 69 | 01.02.09 |
Daniel Swisher
BRD | Director/Board Member | 61 | 26.10.23 |
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01.12.08 |
Sarah O'Dowd
BRD | Director/Board Member | 74 | 12.08.20 |
William Waddill
BRD | Director/Board Member | 67 | 01.07.16 |
Bryan Giraudo
BRD | Director/Board Member | 48 | 16.05.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 58 652 133 | 56 866 179 ( 96,96 %) | 0 | 96,96 % |
Unternehmenskontakt
Protagonist Therapeutics, Inc.
7707 Gateway Boulevard Suite 140
94560-1160, Newark
+
http://www.protagonist-inc.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+22.76% | 1.65 Mrd. | |
+43.36% | 54.63 Mrd. | |
-5.31% | 39.92 Mrd. | |
+14.75% | 26.86 Mrd. | |
-12.56% | 26.22 Mrd. | |
-22.45% | 18.78 Mrd. | |
+25.12% | 12.21 Mrd. | |
+0.04% | 12.16 Mrd. | |
+26.04% | 11.94 Mrd. | |
-11.83% | 10.74 Mrd. |
- Börse
- Aktien
- A2AP32 Aktie
- Unternehmen Protagonist Therapeutics, Inc.